Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction : impact of revascularization therapy.

Gerber, Bernhard;Rousseau, Michel;Ahn , Sylvie A;Le Polain De Waroux, Jean-Benoît;Vanoverschelde, Jean-Louis;et.al.
(2012) Journal of the american college of cardiology : JACC — Vol. 59, n° 9, p. 825-835 (2012)

Files

JAmCollCardiol201259825835.pdf
  • Restricted Access
  • Adobe PDF
  • 849.78 KB

Details

Authors
Show more
Abstract
The purpose of this study was to evaluate the impact of myocardial viability assessment by delayed-enhanced cardiac magnetic resonance (DE-CMR) and of revascularization therapy on survival in patients with coronary artery disease (CAD) and low ejection fraction (EF).
Affiliations

Citations

Gerber, B., Rousseau, M., Ahn, S. A., Le Polain De Waroux, J.-B., Pouleur, A.-C., Phlips, T., Vancraeynest, D., Pasquet, A., & Vanoverschelde, J.-L. (2012). Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction : impact of revascularization therapy. Journal of the american college of cardiology : JACC, 59(9), 825-835. https://doi.org/10.1016/j.jacc.2011.09.073 (Original work published 2012)